FDA approves Merck's Keytruda as breast cancer treatment | The Hill: Healthcare Policy

admin July 27, 2021

The Food and Drug Administration (FDA) approved Merck’s immunotherapy Keytruda for early treatment of triple-negative breast cancer (TNBC) in combination with chemotherapy, the pharmaceutical company announced on Tuesday. The federal agency’s...